Skip to main content

United States News All stories

Every story in this section, newest first — page 354 of 373.

Grafa
Health

HUTCHMED’s savolitinib clinches priority review for gastric cancer in China

HUTCHMED (NASDAQ:HCM) announced on Tuesday that Chinese regulators have accepted its New Drug Application (NDA) for savolitinib and granted it priority review, clearing a path for the drug to become the first selective MET inhibitor approved for gastric cancer in the region.

Read more: HUTCHMED’s savolitinib clinches priority review for gastric cancer in China
Grafa

OceanFirst to acquire Flushing Financial in $579M merger

OceanFirst Financial Corp. (NASDAQ:OCFC) and Flushing Financial Corp. (NASDAQ:FFIC) have entered into a definitive agreement to combine in an all-stock transaction, a deal bolstered by a significant private equity injection that aims to create a powerhouse regional lender in the New York metropolitan area.

Read more: OceanFirst to acquire Flushing Financial in $579M merger